New Treatments for Breast Cancer

A new treatment for breast cancer in breast cancer affects one out of every eight American women and is the cause of the second most cancer deaths in the United States. I chose to write a paper on breast cancer. Because it is an illness that affects my family. Due to this possible genetic condition, studying this topic helps me learn ways to prevent disease, and to help my self to perform self-examination that may lead to early detection I think it will help to educate. Breast cancer is a malignant tumor of glandular tissue.

For example, breast tissue is sensitive (grown) to estrogen. Since breast cancer is derived from normal breast tissue, estrogen also causes the proliferation of breast cancer cells. Therefore, antiestrogen therapy effectively supplements the recurrence of breast cancer (tamoxifen, aromatase inhibitor, etc.). Since prostate cells require testosterone, blocking testosterone (eg by castration) will also help in the treatment of prostate cancer. Knowing what causes tissue growth is valuable information leading to viable cancer treatment.

Breast cancer is the most commonly diagnosed women's cancer in the world, screened and improved with adjuvant therapy, but it is the leading cause of death from cancer. For therapeutic reasons, there are 15 types of cancers that are further subdivided according to their estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Targeted therapies for one of the above targets are available for most patients. These therapy options are not found in patients diagnosed with ER, PR and HER2 deficient tumors. Therefore, these breast cancers are called Triple Negative Breast Cancer (TNBC)

Some breast cancers are boosted by hormonal estrogens and / or progesterone. There are things that are not so. Knowing whether your cancer is sensitive to these hormones is an important part of the therapeutic equation. Hormone receptor positive breast cancer cells have proteins called hormone receptors attached to estrogen and progesterone circulating in the body. Hormone therapy can be used against hormone receptor positive breast cancer. ACS shows that all invasive breast cancer and DCIS should be examined for hormonal status

Some breast cancers are sensitive to hormones produced in the body. In these hormone receptor positive breast cancers, estrogen and / or progesterone promote cancer proliferation. Hormonal therapy lowers estrogen levels in the body or prevents hormones from binding to cancer cells. Such treatment for breast cancer includes the oral drug tamoxifen, which is usually administered to women with hormone receptor positive breast cancer after surgery. In general, breast cancer at stage 0 and stage 1 is highly treatable. The 5-year survival rate of women diagnosed with breast cancer at these early stages is close to 100%. In Phases 2 and 3, 93% and 72% of women can survive for at least 5 years after being diagnosed with breast cancer. Treatment of stage 4 or metastatic breast cancer is difficult. The 5-year survival rate is about 22%